Nucletron appoints Lamers as CEO as part of Delft buy-out

Nucletron has appointed Jos Lamers as its new CEO, which marks the next phase for the company following its management buy-out from Delft Instruments in August 2007.

Lamers has held senior management and board positions at Numico, an Amsterdam, Netherlands-based manufacturer of baby and infant food products, and currently is a member of the executive board at Eurofins Scientific, an international laboratory group offering quality testing and support services, according to the Veenendaal, Netherlands-based Nucletron.

With the appointment of Lamers as CEO, the managing board of Nucletron is complete, with Jeroen Cammeraat as chief operating officer and Jan Sigger as chief financial officer, according to the company. 

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.